Table 2.
Clinical characteristics of the study population according to RTE quartiles.
| Q1 (n = 242) | Q2 (n = 241) | Q3 (n = 242) | Q4 (n = 242) | p | |
|---|---|---|---|---|---|
| Age (years) | 59 + 12 | 55 ± 13 | 53 ± 14 | 46 ± 13 | <0.001 |
| Gender (% male) | 70% | 68% | 63% | 54% | <0.001 |
| Dialysis | 94% | 94% | 89% | 86% | <0.001 |
| Dialysis vintage (months) | 40+34 | 43 ± 34 | 42 ± 38 | 35 ± 30 | <0.001 |
| Diabetes | 28% | 24% | 17% | 10% | <0.001 |
| Hypertension | 82% | 83% | 90% | 87% | 0.019 |
| Body mass index (kg/m2) | 26.2 + 4.7 | 25.8 ± 4.8 | 25.9 ± 5.0 | 24.9 ± 5.1 | 0.541 |
| Past history of cancer | 12% | 9% | 6% | 3% | <0.001 |
| Past history of CVD | 24% | 21% | 18% | 12% | <0.001 |
| Chronic respiratory disease | 4% | 4% | 3% | 4% | 0.482 |
| Percentage of Immunized patients | 30% | 33% | 31% | 30% | 0.521 |
| Pre-transplant CMV exposure | 62% | 61% | 51% | 54% | 0.054 |
| RTE (/mm3) Median (range) | 44 [2–73] | 107 [75–134] | 177 [135–230] | 316 [231–1,136] | <0.001 |